BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Acepodia Partners with Pfizer Ignibiolote to Advance Cell Therapies for Autoimmune Diseases and Oncology

Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyon...

September 04, 2024 | News

Jacobio Pharma Grants China Rights for KRAS G12C and SHP2 Inhibitors to Shanghai Allist in Landmark Deal

Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that it has granted the China ...

September 02, 2024 | News

HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage

A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...

August 28, 2024 | News

CanariaBio Completes Enrollment for Phase 2 Study of Oregovomab with Chemotherapy in Advanced Ovarian Cancer

CanariaBio Inc, a leading late-stage biotechnology company, announces the successful completion of enrollment of 88 patients in a randomized Phase 2 study ...

August 26, 2024 | News

Everest Medicines Launches First Clinical Trial for Personalized mRNA Cancer Vaccine EVM16 in China

Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeut...

August 22, 2024 | News

GE HealthCare and Roche Diagnostics Partner to Transform Precision Cancer Care in Asia Pacific

GE HealthCare and Roche Diagnostics have entered into a Memorandum of Understanding (MOU) that will leverage the strengths and resources of both comp...

August 22, 2024 | News

Akeso’s Ivonescimab Granted Priority Review by China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso, Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People's Republic of China (NMPA CDE) ...

August 15, 2024 | News

Alfred Health Expands Oracle EHR to Enhance Cancer Care and Clinical Trial Access

Leading Victorian healthcare network, Alfred Health, has extended its long-standing Oracle Health footprint with Oracle's Oncology electroni...

August 14, 2024 | News

Angiex Initiates Patient Dosing in Phase 1 Clinical Trial of AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Cancers

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for t...

August 12, 2024 | News

NEC Bio Therapeutics and AGC Biologics Partner to Enhance Production of Personalized Cancer Vaccine

NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria-based D...

August 08, 2024 | News

Beckman Coulter Life Sciences and Illumina Launch Automated Solution for Faster, Comprehensive Oncology Genomic Profiling

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA...

August 07, 2024 | News

GSK Singapore Secures HSA Approval for Jemperli Combo Therapy in Advanced Endometrial Cancer

GSK Singapore is pleased to announce that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperli (dostarlimab). Jemperli ...

August 07, 2024 | News

Thermo Fisher's SeCore™ CDx HLA A Sequencing System Gains FDA Clearance for Use with Adaptimmune’s New TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(...

August 07, 2024 | News

JelloX Biotech Collaborates with Mayo Clinic to Enhance 3D Digital Imaging and AI Analysis for Precision Cancer Diagnosis

JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to f...

August 01, 2024 | News

Stay Connected